Tp53 Mutations Confer Resistance to Hypomethylating Agents and Bcl-2 Inhibition in Myeloid Neoplasms

AuthID
P-014-Z1K
11
Author(s)
Schimmer R.R.
·
Kovtonyuk L.V.
·
Klemm N.
·
Fullin J.
·
Stolz S.M.
·
Mueller J.
·
Kurppa K.J.
·
Ebert B.L.
·
Manz M.G.
·
Boettcher S.
Document Type
Letter
Year published
2022
Published
in Blood Advances, ISSN: 2473-9529
Volume: 6, Issue: 11, Pages: 3201-3206 (5)
Indexing
Publication Identifiers
Pubmed: 35026842
Scopus: 2-s2.0-85132330310
Source Identifiers
ISSN: 2473-9529
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.